The Safety and Effectiveness of Commercially Available Cannabidiol Products for Health and Well-Being: A Randomized, Multi-Arm, Open-Label Waitlist-Controlled Trial

• Päätekijät: Jessica Londeree Saleska (Tekijä), Emily K. Pauli (Tekijä), Panteha Rezvan (Tekijä), Olivia Cobb (Tekijä), Jeff Chen (Tekijä), Pelin Thorogood (Tekijä), Miroslav Backonja (Tekijä), Christopher S. Colwell (Tekijä), Derek Loewy (Tekijä), Ethan Russo (Tekijä), Kate Wolitzky-Taylor (Tekijä), Jill Waalen (Tekijä), Ryan Vandrey (Tekijä), Kelsey T. Laird (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Mary Ann Liebert, 2022-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Introduction: Over the past decade, use of cannabidiol (CBD) to manage common symptoms such as anxiety, sleep disturbance, and pain has expanded rapidly. However, few clinical trials have investigated CBD's safety or efficacy. Furthermore, whether effects vary by characteristics of the product...